Table 3.
The number of 13 terms among 31 resulted terms from enrichment of elements of cluster-2 which are organized in one group are presented. P-value≤0.05, 7≤genes/term, and 5≤%genes/term. The underlined number refers to repeat of term. The repeated terms are shown with underlined numbers
| R | Terms | Genes/Term | %Genes/Term |
|---|---|---|---|
| 1 | NF-Kappa B signaling pathway | 8 | 8 |
| 2 | Cellular senescence_2 | 8 | 5 |
| 3 | Toll-like receptor signaling pathway | 7 | 7 |
| 4 | Jak-STAT signaling pathway | 10 | 6 |
| 5 | Hematopoietic cell lineage_2 | 7 | 7 |
| 6 | IL-17 signaling pathway | 10 | 11 |
| 7 | T cell receptor signaling pathway_1 | 7 | 7 |
| 8 | AGE-RAGE signaling pathway in diabetic complication_2 | 8 | 8 |
| 9 | Pertussis | 8 | 11 |
| 10 | Legionellosis | 8 | 14 |
| 11 | Leishmaniasis_1 | 8 | 11 |
| 12 | Chagas disease (American trypanosomiasis) | 8 | 8 |
| 13 | Malaria_1 | 9 | 17 |
| 14 | Toxoplasmosis_1 | 7 | 6 |
| 15 | Amoebiasis | 9 | 9 |
| 16 | Tuberculosis_1 | 9 | 5 |
| 17 | Hepatitis C_1 | 7 | 5 |
| 18 | Hepatitis B_2 | 12 | 8 |
| 19 | Measles_2 | 9 | 7 |
| 20 | Kaposis sarcoma associated herpes virus infection_2 | 11 | 6 |
| 21 | Proteoglycans in cancer_1 | 15 | 7 |
| 22 | Endometrial cancer | 7 | 12 |
| 23 | Prostate cancer | 7 | 7 |
| 24 | Bladder cancer | 9 | 22 |
| 25 | Chronic myeloid leukemia | 7 | 9 |
| 26 | Gastric cancer_1 | 10 | 6 |
| 27 | Inflammatory bowel disease (IBD)_2 | 11 | 17 |
| 28 | Rheumatoid arthritis | 7 | 8 |